| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,148 |
1,927 |
$101K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
766 |
713 |
$63K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
229 |
217 |
$33K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
182 |
172 |
$13K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
248 |
235 |
$11K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
123 |
118 |
$10K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
317 |
267 |
$6K |
| 90686 |
|
302 |
276 |
$3K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
50 |
46 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
62 |
36 |
$2K |
| 96160 |
|
86 |
78 |
$1K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
14 |
14 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
75 |
72 |
$912.21 |
| 85018 |
|
13 |
13 |
$30.16 |